Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2

Abstract

BackgroundDiabetes is one of the most common comorbidities in COVID-19 patients that pertains to disease severity, but the causal mechanism regarding its negative impact on COVID-19 outcome has yet been uncovered.MethodsWe retrospectively analyzed 459 COVID-19 patients admitted in early 2020 and 336 COVID-19 patients admitted in August 2021, with their demographic information, medical history, vaccination status (if applied), and laboratory data reported.ResultsAmong COVID-19 patients, compared to the non-diabetic group, the diabetic group exhibited elder age, higher proportion of patients with other major comorbidities, more severe dysfunction of innate immune cells, more refractory blood coagulopathy and more detrimental organ damage. For the wild-type SARS-CoV-2 infection, diabetic comorbidity was associated with COVID-19 severity but not mortality, and the glycemic levels in the non-diabetic group upon infection experienced high and analogous to those in the diabetic group. Besides, infected by the delta variant of SARS-CoV-2, the non-diabetic patients did not demonstrate hyperglycemia, and despite different vaccination statuses, the diabetic patients exhibited comparable antibody responses to non-diabetic, showing the robustness of acquired immunity.ConclusionsSARS-CoV-2 infection may superimpose the deterioration of innate immune systems in diabetic patients, which contributes to their worsened disease outcome, but timely COVID-19 immunization could provide adequate protection in diabetic population that leads to favored prognosis.

Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)

“…Specifically for influenza, DM is associated with a higher frequency and more severe clinical course, similarly, also mycobacterial infections may be more frequent and more severe in individuals with DM 27. Diabetes is also a known risk factor for SARS-CoV-2 infection as well as worse COVID-19-related mortality 7 28–34. In a study from England, obesity itself was associated with higher COVID-19-related hospitalization or death even within the vaccinated cohort after adjustment for the presence of DM 31…”

Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions

“…Viruses and host immunity may also be correlated, indicating a certain evolutionary direction. 13 , 14 , 15 , 16 It has been reported that approximately 10% of hospitalized patients are susceptible to COVID‐19, which is associated with prolonged hospital stay and increased risk of postoperative complications, particularly in elderly patients with diabetes, chronic obstructive pulmonary disease, or other frail or immune abnormalities. The increase in COVID‐19 cases will bring additional challenges and increase global medical burden.…”

Clinical Outcome of COVID-19 Infection on Chronic Diabetic Complications Patients

“…COVID-19, which infects patients with comorbid diabetes mellitus will worsen the patient's condition (Zhang et al, 2022). In a study, it was stated that in patients infected with COVID-19 and having type 2 diabetes mellitus, viral shedding was prolonged, while the duration of viral shedding is positively associated with the level of severity (Arfijanto et al, 2023).…”